Search - tctmd.com

Displaying 1 - 20 of 629

Sort: Relevancy | Date

News Conference News STS 2026

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

Yael L. Maxwell

February 10, 2026

News Conference News STS 2026

Latest STS Compensation Data Show Pay Is Up but Still Lags for Female Surgeons

Yael L. Maxwell

February 02, 2026

News Daily News

Heart Disease Remains Number One Killer of Americans

L.A. McKeown

January 22, 2026

News Daily News

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

Yael L. Maxwell

January 21, 2026

News Daily News

HF Care Differs Among Asian Subgroups in the US

L.A. McKeown

January 16, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

Caitlin E. Cox

December 10, 2025

Presentation TCT 2025

MAGICAL ISR and SV: The US IDE Trials Landscape

Presenter: Azeem Latib

October 27, 2025

Presentation TCT 2025

Global case presentation of Sirolimus Coated Balloon III

Presenter: Ankit Gupta

October 27, 2025

Presentation TCT 2025

Global case presentation of Sirolimus Coated Balloon II - Cases from the TRANSFORM-II Trial for De novo disease

Presenter: Daniel A. Jones

October 27, 2025

Presentation TCT 2025

Global case presentation of Sirolimus Coated Balloon I

Presenter: Sandeep Basavarajaiah

October 27, 2025

Presentation TCT 2025

MagicTouch Clinical Trial Program: the role of SCB in coronary revascularization

Presenter: Daniela Benedetto

October 27, 2025

Presentation TCT 2025

How and Where to use a Sirolimus Coated Balloon? Learnings from my experience and results from the GINGER Trial

Presenter: Antonio Colombo

October 27, 2025

Presentation TCT 2025

TCT 298: Black Race Associated With Higher Mortality and Heart Failure After CABG: A Real-World Matched Cohort Study

Presenter: Ronak Bharucha

October 27, 2025

Presentation TCT 2025

TCT 1154: The Relationship Between Race and Post-TAVR Bleeding Outcomes: Analysis from the Trans-Pacific TAVR (TP-TAVR) Registry

Presenter: Meghana Iyer

October 27, 2025

News Daily News

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

Caitlin E. Cox

October 21, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Caitlin E. Cox

October 08, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

Heart Disease Treatment Costs $100 Billion per Year in the US

L.A. McKeown

July 30, 2025

Advertisement

‘Concerning’ Trends Seen in Aortic Stenosis-Related Mortality: CDC WONDER

Latest STS Compensation Data Show Pay Is Up but Still Lags for Female Surgeons

Heart Disease Remains Number One Killer of Americans

Previewing 30-Year ASCVD Risk May Open Door to Earlier Treatment

HF Care Differs Among Asian Subgroups in the US

JACC Debuts Data Digest on CV Health in the United States

Uterine Fibroids Increase Future Risk of ASCVD for Up to 10 Years

MAGICAL ISR and SV: The US IDE Trials Landscape

Global case presentation of Sirolimus Coated Balloon III

Global case presentation of Sirolimus Coated Balloon II - Cases from the TRANSFORM-II Trial for De novo disease

Global case presentation of Sirolimus Coated Balloon I

MagicTouch Clinical Trial Program: the role of SCB in coronary revascularization

How and Where to use a Sirolimus Coated Balloon? Learnings from my experience and results from the GINGER Trial

TCT 298: Black Race Associated With Higher Mortality and Heart Failure After CABG: A Real-World Matched Cohort Study

TCT 1154: The Relationship Between Race and Post-TAVR Bleeding Outcomes: Analysis from the Trans-Pacific TAVR (TP-TAVR) Registry

Disparities in MCS Use for STEMI-Related Shock Seen Across the US

What’s Going to Be Hot at TCT 2025

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Heart Disease Treatment Costs $100 Billion per Year in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content